Red Meat, Plant Protein, and Colitis: Emerging Roles for the Gut Microbiome and Bile Acids

Patients with inflammatory bowel disease (IBD) frequently seek dietary guidance to help manage symptoms and reduce disease activity, yet evidence-based dietary recommendations remain limited.¹ Although adequate protein intake is important for maintaining nutritional status and supporting recovery from chronic inflammation, emerging evidence suggests that the effects of dietary protein cannot be considered independently of the overall dietary pattern.^1,2 Animal- and plant-derived proteins are typically consumed within distinct dietary contexts that differ in fiber content, food structure, and associated bioactive compounds, all of which can influence gut microbial ecology and host metabolism.^3,4 Consequently, understanding how protein sources interact with the broader dietary environment may provide important insights into the dietary factors that contribute to intestinal inflammation and disease progression in IBD.

In this issue of Cellular and Molecular Gastroenterology and Hepatology, Gray et al address this important question by comparing the effects of animal- and plant-derived protein sources in both acute and chronic murine models of colitis. The authors demonstrate that mice fed a beef protein diet developed more severe intestinal inflammation than those receiving a pea protein diet, with consistent effects observed across multiple models of disease. Importantly, these differences were largely dependent on the gut microbiota, as evidenced by microbial depletion and microbiota transplantation experiments. In addition to alterations in microbial composition, beef protein feeding was associated with changes in fecal bile acid profiles, including increased levels of primary and conjugated bile acids. Furthermore, administration of taurocholic acid exacerbated colitis severity, suggesting that bile acid metabolism may represent a functional link between dietary protein source and intestinal inflammation. Together, these findings provide new evidence that dietary proteins can influence host inflammatory responses through interactions with the gut microbiome and its metabolic activities, including bile acid metabolism.^5,6

An intriguing aspect of the study is the observation that beef protein feeding promoted the expansion of Akkermansia muciniphila, accompanied by reduced mucus thickness and quality. Although A muciniphila is frequently associated with improved metabolic health and has been widely investigated as a beneficial commensal, accumulating evidence suggests that its physiological effects are highly context-dependent.⁷ As a mucin-degrading bacterium, A muciniphila may contribute to either maintenance or disruption of the mucus barrier depending on dietary composition and substrate availability.^7,8 Recent studies have demonstrated that dietary fiber availability can profoundly influence host–microbe interactions and determine whether mucin utilization supports intestinal homeostasis or promotes barrier dysfunction.⁸ In this context, the protective effects of psyllium are particularly noteworthy. Psyllium supplementation attenuated beef protein–associated inflammation, restored bile acid–modulating commensals, and normalized bile acid profiles, indicating that the impact of dietary protein cannot be considered independently of the broader dietary environment.^9,10 These findings highlight the complex interplay among dietary proteins, fiber, microbial metabolism, and intestinal barrier function in shaping susceptibility to colitis.

This study contributes to a growing body of evidence that dietary factors influence intestinal inflammation not only through direct effects on the host but also through their ability to shape microbial metabolism and function. By identifying bile acids as potential mediators linking dietary protein sources to colitis severity, the authors highlight the importance of functional interactions among diet, the gut microbiome, and host physiology. Significantly, the findings draw attention to dietary protein source as a potentially important, yet understudied, determinant of intestinal inflammation. Yet, whether these relationships extend to patients with IBD remains to be determined. Nevertheless, this work broadens the discussion surrounding diet and IBD and raises critical questions regarding how different protein sources, in addition to overall dietary patterns, may shape the intestinal environment in health and disease.